Ask AI
Rare Blood Diseases YIR

CME

Key Advances in Rare Blood Diseases in 2024: A Year in Review

Physicians: Maximum of 0.25 AMA PRA Category 1 Credit

Released: January 30, 2025

Expiration: January 29, 2026

Pretest

Progress
1 2
Course Completed
1.

Which of the following therapies is approved for routine prophylaxis in adult and pediatric patients 12 years of age or older with hemophilia A or B with factor VIII or factor IX inhibitors, respectively?